Institutionalisation of markets for innovative health technologies: The case of personalised cancer medicine in the Netherlands

E.H.M. Moors; P. Kukk; W.P.C. Boon; S.O. Negro

Institutionalisation of markets for innovative health technologies: The case of personalised cancer medicine in the Netherlands

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 2016
Event	2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden - Duration: 7 Jun 2016 → 10 Jun 2016

Conference

Conference	2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden
Period	7/06/16 → 10/06/16

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Transition
Technological innovation system
Institutionalization
Market formation
Personalised cancer medicine
Valorisation

Cite this

@conference{b7bb09661d684e81b6be0648791b0186,

title = "Institutionalisation of markets for innovative health technologies: The case of personalised cancer medicine in the Netherlands",

keywords = "Transition, Technological innovation system, Institutionalization, Market formation, Personalised cancer medicine, Valorisation",

author = "E.H.M. Moors and P. Kukk and W.P.C. Boon and S.O. Negro",

year = "2016",

language = "English",

note = "2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden ; Conference date: 07-06-2016 Through 10-06-2016",

}

Institutionalisation of markets for innovative health technologies: The case of personalised cancer medicine in the Netherlands. / Moors, E.H.M.; Kukk, P.; Boon, W.P.C. et al.
2016. Abstract from 2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Institutionalisation of markets for innovative health technologies: The case of personalised cancer medicine in the Netherlands

AU - Moors, E.H.M.

AU - Kukk, P.

AU - Boon, W.P.C.

AU - Negro, S.O.

PY - 2016

Y1 - 2016

KW - Transition

KW - Technological innovation system

KW - Institutionalization

KW - Market formation

KW - Personalised cancer medicine

KW - Valorisation

M3 - Abstract

T2 - 2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden

Y2 - 7 June 2016 through 10 June 2016

ER -